Tycho Peterson
Stock Analyst at Jefferies
(4.43)
# 1,107
Out of 4,405 analysts
416
Total ratings
54.4%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintained: Buy | $585 → $650 | $469.34 | +38.49% | 27 | May 27, 2026 | |
| WGS GeneDx Holdings | Maintained: Buy | $150 → $100 | $59.92 | +66.89% | 9 | May 27, 2026 | |
| BIO Bio-Rad Laboratories | Maintained: Hold | $285 → $275 | $285.94 | -3.83% | 4 | May 21, 2026 | |
| QGEN Qiagen | Maintained: Buy | n/a | $37.06 | - | 27 | May 7, 2026 | |
| QDEL QuidelOrtho | Downgraded: Hold | $35 → $13 | $14.18 | -11.82% | 13 | May 7, 2026 | |
| DHR Danaher | Reiterated: Buy | $265 → $245 | $180.10 | +36.04% | 17 | Apr 22, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | $220 → $225 | $203.06 | +10.80% | 6 | Apr 21, 2026 | |
| VCYT Veracyte | Initiated Coverage: Buy | $45 | $47.33 | -4.92% | 1 | Apr 12, 2026 | |
| TEM Tempus AI | Initiated Coverage: Sell | $35 | $47.82 | -26.81% | 1 | Apr 12, 2026 | |
| CAI Caris Life Sciences | Initiated Coverage: Buy | $28 | $17.97 | +55.82% | 1 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1,150 → $1,450 | $1,131.49 | +28.15% | 12 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $105.48 | +9.03% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $21 | $28.84 | -27.18% | 11 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $54.23 | -7.80% | 18 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $8 | $9.39 | -14.80% | 13 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $355.53 | +32.20% | 24 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 → $105 | $99.66 | +5.36% | 13 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $139 | $119.05 | +16.76% | 4 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $275 | $212.07 | +29.67% | 13 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $130 | $131.62 | -1.23% | 12 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.87 | +167.38% | 1 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $117 | $101.12 | +15.70% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 | $129.84 | +0.12% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $300 | $266.16 | +12.71% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310 | $265.41 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4.5 | $2.40 | n/a | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $1.31 | n/a | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $20 → $11 | $4.33 | n/a | 16 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $11.15 | n/a | 3 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 | $26.10 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $121 → $145 | $160.97 | n/a | 22 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $22.97 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $215 → $165 | $130.59 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $2.24 | n/a | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.98 | n/a | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $6 | $4.18 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $35 → $18 | $16.19 | n/a | 3 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 → $315 | $146.18 | n/a | 6 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $8 | $1.13 | n/a | 2 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $25 | $6.80 | n/a | 3 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $18 | $4.88 | n/a | 2 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $15 | $1.76 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $60 | $3.10 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $25 | $1.72 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 → $55 | $10.09 | n/a | 7 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $17.60 | n/a | 4 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 → $310 | $181.46 | n/a | 13 | Feb 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 → $65 | $76.17 | n/a | 5 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 → $333 | $411.06 | n/a | 19 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $375 → $390 | $187.51 | n/a | 6 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $30 | $24.60 | n/a | 3 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.3413 | n/a | 8 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $25 | $4.45 | n/a | 6 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $1.26 | n/a | 1 | Aug 4, 2016 |
Thermo Fisher Scientific
May 27, 2026
Maintained: Buy
Price Target: $585 → $650
Current: $469.34
Upside: +38.49%
GeneDx Holdings
May 27, 2026
Maintained: Buy
Price Target: $150 → $100
Current: $59.92
Upside: +66.89%
Bio-Rad Laboratories
May 21, 2026
Maintained: Hold
Price Target: $285 → $275
Current: $285.94
Upside: -3.83%
Qiagen
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $37.06
Upside: -
QuidelOrtho
May 7, 2026
Downgraded: Hold
Price Target: $35 → $13
Current: $14.18
Upside: -11.82%
Danaher
Apr 22, 2026
Reiterated: Buy
Price Target: $265 → $245
Current: $180.10
Upside: +36.04%
Quest Diagnostics
Apr 21, 2026
Maintained: Buy
Price Target: $220 → $225
Current: $203.06
Upside: +10.80%
Veracyte
Apr 12, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $47.33
Upside: -4.92%
Tempus AI
Apr 12, 2026
Initiated Coverage: Sell
Price Target: $35
Current: $47.82
Upside: -26.81%
Caris Life Sciences
Apr 12, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $17.97
Upside: +55.82%
Mar 19, 2026
Upgraded: Buy
Price Target: $1,150 → $1,450
Current: $1,131.49
Upside: +28.15%
Mar 11, 2026
Maintained: Buy
Price Target: $115
Current: $105.48
Upside: +9.03%
Feb 13, 2026
Reiterated: Buy
Price Target: $19 → $21
Current: $28.84
Upside: -27.18%
Feb 12, 2026
Maintained: Buy
Price Target: $60 → $50
Current: $54.23
Upside: -7.80%
Feb 12, 2026
Reiterated: Sell
Price Target: $9 → $8
Current: $9.39
Upside: -14.80%
Feb 10, 2026
Reiterated: Buy
Price Target: $470
Current: $355.53
Upside: +32.20%
Feb 2, 2026
Maintained: Hold
Price Target: $100 → $105
Current: $99.66
Upside: +5.36%
Dec 19, 2025
Maintained: Buy
Price Target: $139
Current: $119.05
Upside: +16.76%
Dec 17, 2025
Maintained: Buy
Price Target: $200 → $275
Current: $212.07
Upside: +29.67%
Dec 17, 2025
Maintained: Buy
Price Target: $75 → $130
Current: $131.62
Upside: -1.23%
Dec 14, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.87
Upside: +167.38%
Dec 1, 2025
Initiated Coverage: Hold
Price Target: $117
Current: $101.12
Upside: +15.70%
Oct 17, 2025
Maintained: Hold
Price Target: $130
Current: $129.84
Upside: +0.12%
Jul 25, 2025
Reiterated: Buy
Price Target: $290 → $300
Current: $266.16
Upside: +12.71%
May 20, 2025
Maintained: Buy
Price Target: $310
Current: $265.41
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $5 → $4.5
Current: $2.40
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $1.31
Upside: n/a
Feb 25, 2025
Maintained: Sell
Price Target: $20 → $11
Current: $4.33
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: $22 → $18
Current: $11.15
Upside: n/a
Dec 16, 2024
Rated: Buy
Price Target: $31
Current: $26.10
Upside: n/a
Oct 31, 2024
Maintained: Hold
Price Target: $121 → $145
Current: $160.97
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: $30
Current: $22.97
Upside: n/a
Jun 3, 2024
Maintained: Hold
Price Target: $215 → $165
Current: $130.59
Upside: n/a
Jun 3, 2024
Downgraded: Hold
Price Target: $3
Current: $2.24
Upside: n/a
Jun 3, 2024
Maintained: Buy
Price Target: $11
Current: $4.98
Upside: n/a
May 13, 2024
Maintained: Hold
Price Target: $10 → $6
Current: $4.18
Upside: n/a
Jan 23, 2023
Upgraded: Hold
Price Target: $35 → $18
Current: $16.19
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $325 → $315
Current: $146.18
Upside: n/a
Apr 1, 2022
Maintained: Hold
Price Target: $16 → $8
Current: $1.13
Upside: n/a
Mar 23, 2022
Maintained: Buy
Price Target: $28 → $25
Current: $6.80
Upside: n/a
Mar 15, 2022
Maintained: Buy
Price Target: $23 → $18
Current: $4.88
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $30 → $15
Current: $1.76
Upside: n/a
Mar 2, 2022
Maintained: Buy
Price Target: $40 → $60
Current: $3.10
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $75 → $25
Current: $1.72
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $47 → $55
Current: $10.09
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $60 → $50
Current: $17.60
Upside: n/a
Feb 15, 2022
Maintained: Buy
Price Target: $300 → $310
Current: $181.46
Upside: n/a
Feb 4, 2022
Maintained: Sell
Price Target: $100 → $65
Current: $76.17
Upside: n/a
Jul 21, 2021
Maintained: Buy
Price Target: $300 → $333
Current: $411.06
Upside: n/a
May 28, 2021
Maintained: Buy
Price Target: $375 → $390
Current: $187.51
Upside: n/a
Oct 30, 2020
Maintained: Buy
Price Target: $27 → $30
Current: $24.60
Upside: n/a
Dec 13, 2017
Downgraded: Sell
Price Target: n/a
Current: $0.3413
Upside: n/a
Mar 1, 2017
Maintained: Hold
Price Target: $34 → $25
Current: $4.45
Upside: n/a
Aug 4, 2016
Reiterated: Hold
Price Target: $8
Current: $1.26
Upside: n/a